Oculis, a global biopharmaceutical company developing treatments to save sight and improve eye care, is merging with European Biotech Acquisition Corp (EBAC), a listed special purpose acquisition company (SPAC). Upon…
Switzerland: Oculis going public through SPAC merger
…
…






